Molecular Classification of Myeloma Cell Lines Is Related to that of Patients with Myeloma

被引：0
|
作者：
Moreaux, J. [1 ]
Pellat-Deceunynck, C. [1 ]
Klein, B. [1 ]
Reme, T. [1 ]
Jourdan, M. [1 ]
Descamps, G. [1 ]
Maiga, S. [1 ]
Bataille, R. [1 ]
Amiot, M. [1 ]
机构：
[1] INSERM, U847, F-75654 Paris 13, France
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70705-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [1] A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
    Moreaux, Jerome
    Klein, Bernard
    Bataille, Regis
    Descamps, Geraldine
    Maiga, Sophie
    Hose, Dirk
    Goldschmidt, Hartmut
    Jauch, Anna
    Reme, Thierry
    Jourdan, Michel
    Amiot, Martine
    Pellat-Deceunynck, Catherine
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 574 - 582
  • [2] Unsupervised Analysis of Gene Expression Profile of 37 Human Myeloma Cell Lines Identifies 5 Classes of HMCL Characterized by a Set of 213 Genes Related to Molecular Classification of Patients with Multiple Myeloma.
    Moreaux, Jerome
    Klein, Bernard
    Reme, Thierry
    Jourdan, Michel
    Maiga, Sophie
    Bataille, Regis
    Amiot, Martine
    Pellat-Deceunynck, Catherine
    BLOOD, 2008, 112 (11) : 934 - 935
  • [3] The molecular classification of multiple myeloma
    Zhan, Fenghuang
    Huang, Yongsheng
    Colla, Simona
    Stewart, James P.
    Hanamura, Ichiro
    Gupta, Sushil
    Epstein, Joshua
    Yaccoby, Shmuel
    Sawyer, Jeffrey
    Burington, Bart
    Anaissie, Elias
    Hollmig, Klaus
    Pineda-Roman, Mauricio
    Tricot, Guido
    van Rhee, Frits
    Walker, Ronald
    Zangari, Maurizio
    Crowley, John
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2006, 108 (06) : 2020 - 2028
  • [4] Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patients
    Meinhardt, G
    Dayyani, F
    Jahrsdörfer, B
    Baumgart, J
    Emmerich, B
    Schmidmaier, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (06) : 892 - 899
  • [5] Phenotypic and molecular characterisation of putative human myeloma cell lines
    Gooding, R
    Bybee, A
    Gupta, D
    Cooke, F
    Coelho, E
    Samson, DM
    Apperley, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 487 - 487
  • [6] Molecular classification and risk stratification of myeloma
    Bergsagel, P. Leif
    Chesi, Marta
    HEMATOLOGICAL ONCOLOGY, 2013, 31 : 38 - 41
  • [7] Phenotypic and molecular characterisation of putative human myeloma cell lines.
    Gooding, R
    Coelho, E
    Bybee, A
    Dupta, D
    Cooke, F
    Samson, DM
    Apperley, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 312 - 312
  • [8] SPARC GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS AND ITS REGULATION BY CYTOTOXIC TREATMENTS IN MYELOMA CELL LINES
    Kusec, R.
    Grcevic, D.
    Martinovic, M.
    Ajdukovic, R.
    Haris, V.
    Jaksic, O.
    Pejsa, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 376 - 376
  • [9] Expression of RANKL in myeloma cell lines and bone marrow plasma cells in patients with multiple myeloma.
    Sezer, O
    Heider, U
    Jakob, C
    Eucker, J
    Niemöller, K
    Zavrski, I
    Possinger, K
    BLOOD, 2001, 98 (11) : 304B - 304B
  • [10] International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
    Fonseca, R.
    Bergsagel, P. L.
    Drach, J.
    Shaughnessy, J.
    Gutierrez, N.
    Stewart, A. K.
    Morgan, G.
    Van Ness, B.
    Chesi, M.
    Minvielle, S.
    Neri, A.
    Barlogie, B.
    Kuehl, W. M.
    Liebisch, P.
    Davies, F.
    Chen-Kiang, S.
    Durie, B. G. M.
    Carrasco, R.
    Sezer, Orhan
    Reiman, Tony
    Pilarski, Linda
    Avet-Loiseau, H.
    LEUKEMIA, 2009, 23 (12) : 2210 - 2221
12345